The effect of Danshen extract on lipoprotein-associated phospholipase A(2) levels in patients with stable angina pectoris: study protocol for a randomized controlled trial - the DOLPHIN study

BACKGROUND: Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)), a biomarker of oxidation and inflammation, has been associated with increased coronary artery disease risk. To date, very few studies have examined the Chinese herbal drug Danshen or its extract on Lp-PLA(2) in patients with stable a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, A-Di, Wang, Chun-Ling, Qin, Yang, Tian, Liang, Chen, Li-Bin, Yuan, Xiao-Ming, Ma, Lin-Xiu, Wang, Yu-Feng, Sun, Ji-Rong, Wang, Hao-Sen, Dai, Neng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738193/
https://www.ncbi.nlm.nih.gov/pubmed/29262859
http://dx.doi.org/10.1186/s13063-017-2336-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738193/
https://www.ncbi.nlm.nih.gov/pubmed/29262859
http://dx.doi.org/10.1186/s13063-017-2336-2

Ejemplares similares